APA (7th ed.) Citation

Li, D., Ambrogio, L., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L. R., . . . Wong, K. (2008). BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene, 27(34), 4702. https://doi.org/10.1038/onc.2008.109

Chicago Style (17th ed.) Citation

Li, D., et al. "BIBW2992, an Irreversible EGFR/HER2 Inhibitor Highly Effective in Preclinical Lung Cancer Models." Oncogene 27, no. 34 (2008): 4702. https://doi.org/10.1038/onc.2008.109.

MLA (9th ed.) Citation

Li, D., et al. "BIBW2992, an Irreversible EGFR/HER2 Inhibitor Highly Effective in Preclinical Lung Cancer Models." Oncogene, vol. 27, no. 34, 2008, p. 4702, https://doi.org/10.1038/onc.2008.109.